Pathology

Article Pathology

Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer

Lynette M. Sholl

Summary: Immunotherapy is crucial in the management of non-small cell lung carcinoma, but responses vary widely. PD-L1 protein expression serves as a predictive biomarker, yet its sensitivity and specificity are suboptimal. Insights into tumor and host immune-specific factors are defining better immunotherapy biomarkers beyond immune checkpoint expression status.

MODERN PATHOLOGY (2022)

Article Dermatology

Post-COVID-19 vaccination IgA vasculitis in an adult

Marc E. Grossman, Gerald Appel, Alicia J. Little, Christine J. Ko

Summary: This report suggests that IgA vasculitis with skin and renal involvement could be a potential reaction to COVID-19 vaccination, even though SARS-CoV spike protein immunohistochemical staining was negative.

JOURNAL OF CUTANEOUS PATHOLOGY (2022)

Article Clinical Neurology

Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons

Sebastiaan Moonen, Marta J. Koper, Evelien Van Schoor, Jolien M. Schaeverbeke, Rik Vandenberghe, Christine A. F. von Arnim, Thomas Tousseyn, Bart De Strooper, Dietmar Rudolf Thal

Summary: The study investigated the contribution of pyroptosis, a pro-inflammatory mechanism of cell death downstream of the inflammasome, to neurodegeneration in Alzheimer's disease (AD). The findings suggest the activation of pyroptosis in specific cell types and its potential link to neuron death in AD.

ACTA NEUROPATHOLOGICA (2023)

Article Oncology

Deep learning identifies inflamed fat as a risk factor for lymph node metastasis in early colorectal cancer

Scarlet Brockmoeller, Amelie Echle, Narmin Ghaffari Laleh, Susanne Eiholm, Marie Louise Malmstrom, Tine Plato Kuhlmann, Katarina Levic, Heike Irmgard Grabsch, Nicholas P. West, Oliver Lester Saldanha, Katerina Kouvidi, Aurora Bono, Lara R. Heij, Titus J. Brinker, Ismayil Gogenur, Philip Quirke, Jakob Nikolas Kather

Summary: Using deep learning algorithm, this study accurately predicted lymph node metastasis in colorectal cancer patients, showing potential in discovering new biological mechanisms in cancer progression.

JOURNAL OF PATHOLOGY (2022)

Review Pathology

miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay

Ahmed S. Doghish, Mohamed A. Ali, Salah S. Elyan, Mahmoud A. Elrebehy, Hend H. Mohamed, Reda M. Mansour, Ayatallah Elgohary, Aml Ghanem, Ahmed H. I. Faraag, Nourhan M. Abdelmaksoud, Hebatallah Ahmed Mohamed Moustafa

Summary: Cervical cancer is a leading cause of cancer deaths in underdeveloped countries, with persistent infection of high-risk HPV playing a significant role in its development. MicroRNAs are small chain nucleic acids that can regulate various cellular events, including invasion, pathophysiology, angiogenesis, apoptosis, proliferation, and cell cycle phases in cervical cancer. Further research is needed to fully understand the potential of miRNAs in diagnosing and treating cervical cancer.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Clinical Neurology

Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between brain regions

Ryan Gober, Maryam Ardalan, Seyedeh Marziyeh Jabbari Shiadeh, Linda Duque, Susanna P. Garamszegi, Maureen Ascona, Ayled Barreda, Xiaoyan Sun, Carina Mallard, Regina T. Vontell

Summary: This study examined the differential activation of microglia in the brains of individuals with SCZ, finding an increase in microglia density in certain brain regions, as well as region-dependent changes in microglial morphology. The results suggest potential therapeutic targets based on the age-related association with reduced microglial arborization in specific brain regions, providing insights into longitudinal changes in microglial activation across age.

BRAIN PATHOLOGY (2022)

Review Clinical Neurology

Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease

Lucia Viejo, Ayush Noori, Emily Merrill, Sudeshna Das, Bradley T. Hyman, Alberto Serrano-Pozo

Summary: Through a systematic review of astrocyte immunohistochemical studies in post-mortem Alzheimer's disease (AD) brains and subsequent bioinformatics analyses, a wide range of functional alterations including neuroinflammation, oxidative stress and antioxidant defense, lipid metabolism, proteostasis, extracellular matrix organization, and neurotransmission were identified. Furthermore, potential transcription factors driving these changes were identified, with validation from existing -omics datasets showing significant overlap with reported transcriptomic and proteomic changes in AD brains and/or CSF.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)

Review Cell Biology

WHO 2022 landscape of papillary and chromophobe renal cell carcinoma

Joao Lobo, Riuko Ohashi, Mahul B. Amin, Daniel M. Berney, Eva M. Comperat, Ian A. Cree, Anthony J. Gill, Arndt Hartmann, Santosh Menon, George J. Netto, Maria R. Raspollini, Mark A. Rubin, Puay Hoon Tan, Satish K. Tickoo, Toyonori Tsuzuki, Samra Turajlic, Ming Zhou, John R. Srigley, Holger Moch

Summary: The 5th edition of the WHO Classification of Tumours of the Urinary and Male Genital Systems introduces molecularly defined renal tumour subtypes, eliminates the subcategorization of papillary renal cell carcinoma (pRCC), includes emerging entities within the pRCC spectrum, introduces a category of 'other oncocytic tumours', accepts eosinophilic solid and cystic RCC as a new entity, and highlights the need for a reproducible grading system for chromophobe renal cell carcinoma (chRCC).

HISTOPATHOLOGY (2022)

Review Pathology

Lysophospholipid Mediators in Health and Disease

Kuniyuki Kano, Junken Aoki, Timothy Hla

Summary: Lysophospholipids, such as lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), are important extracellular lipid mediators that signal through specific G protein-coupled receptors. They play crucial roles in various biological processes and diseases, including cellular stress signaling, inflammation, and host defense responses. LPA is involved in regulating fibrosis, neuropathic pain, abnormal angiogenesis, endometriosis, and neuroectodermal developmental disorders, while S1P controls collective behavior, apoptotic cell clearance, and immunesurveillance of cancers. The study of lysophospholipids has led to the development of new therapeutics for autoimmune diseases and holds promise for future treatments of fibrotic disorders, vascular diseases, and cancer.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)

Review Pathology

miRNAs as potential game-changers in melanoma: A comprehensive review

Gamil M. Abd-Allah, Ahmed Ismail, Hesham A. El-Mahdy, Elsayed G. E. Elsakka, Ahmed A. El-Husseiny, Nourhan M. Abdelmaksoud, Aya Salman, Samy Y. Elkhawaga, Ahmed S. Doghish

Summary: Melanoma, accounting for 1.7% of all cancer cases worldwide, is the sixth most frequent malignancy. Various risk factors, such as ultraviolet radiation, skin phenotype, pigmented nevi, pesticides, genetics, and epigenetics, are associated with melanoma. Microribonucleic acids (miRNAs), as one of the main epigenetic factors affecting melanoma, can prevent the expression of target genes and regulate multiple signaling pathways related to melanoma initiation, stemness, angiogenesis, apoptosis, proliferation, and treatment resistance. The abundance and stability of miRNAs may serve as important factors for their potential use as markers for prognosis, diagnosis, stemness, survival, and metastasis in melanoma patients.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Pathology

TRPS1 Expression in Breast Carcinomas Focusing on Metaplastic Breast Carcinomas

Bryce Parkinson, Wei Chen, Tiansheng Shen, Anil Parwani, Zaibo Li

Summary: TRPS1 is a highly sensitive and specific marker for breast carcinomas, and its expression is associated with tumor subtypes and HER2 protein.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Article Medical Laboratory Technology

Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas

Daniel J. Brat, Kenneth Aldape, Julia A. Bridge, Peter Canoll, Howard Colman, Meera R. Hameed, Brent T. Harris, Eyas M. Hattab, Jason T. Huse, Robert B. Jenkins, Dolores H. Lopez-Terrada, William C. McDonald, Fausto J. Rodriguez, Lesley H. Souter, Carol Colasacco, Nicole E. Thomas, Michelle Hawks Yount, Martin J. van den Bent, Arie Perry

Summary: This article provides evidence-based recommendations for molecular biomarker testing in diffuse gliomas (DGs) and suggests appropriate laboratory methods and biomarkers selection to inform clinical management.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2022)

Article Clinical Neurology

BTK inhibition limits B-cell-T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy

Rui Li, Hao Tang, Jeremy C. Burns, Brian T. Hopkins, Carole Le Coz, Bo Zhang, Isabella Peixoto de Barcelos, Neil Romberg, Amy C. Goldstein, Brenda L. Banwell, Eline T. Luning Prak, Michael Mingueneau, Amit Bar-Or

Summary: Inhibition of Bruton's Tyrosine Kinase (BTKi) is a promising therapy for autoimmune diseases. This study demonstrates that BTKi attenuates B-cell:T-cell interactions by modulating B-cell metabolic pathways and mediates an anti-inflammatory modulation of B cells. The study suggests that targeting B-cell metabolism may be a viable therapeutic approach for pro-inflammatory B cells.

ACTA NEUROPATHOLOGICA (2022)

Review Pathology

International Consensus Classification of acute lymphoblastic leukemia/lymphoma

Amy S. Duffield, Charles G. Mullighan, Michael J. Borowitz

Summary: The updated International Consensus Classification (ICC) of B-acute lymphoblastic leukemia (B-ALL) and T-acute lymphoblastic leukemia (T-ALL) includes revisions to previous subtypes and new entities. The classification incorporates recent clinical, cytogenetic, and molecular data, emphasizing whole transcriptome analysis and gene expression clustering studies. The new classification allows for improved risk stratification and optimized treatment plans for ALL patients.

VIRCHOWS ARCHIV (2023)

Review Cell Biology

The RASopathies: from pathogenetics to therapeutics

Katie E. Hebron, Edjay Ralph Hernandez, Marielle E. Yohe

Summary: The RASopathies are a group of disorders caused by germline mutations in genes encoding components of the RAS/MAPK pathway. This review discusses the pathogenesis of RASopathy-associated genetic variants and the knowledge gained about RAS/MAPK signaling through studying RASopathies. It also explores cell and animal models of RASopathies, emerging RASopathy genes, and the potential use of targeted agents for treating RASopathies. Lastly, it discusses how drugs targeting RAS/MAPK-driven malignancies could be leveraged for patients with RASopathies.

DISEASE MODELS & MECHANISMS (2022)

Review Pathology

The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition

Merva Soluk-Tekkesin, John M. Wright

Summary: This article reviews the updates in the 5th edition of the World Health Organization classification of head and neck tumors, focusing on the changes and new diagnostic criteria for odontogenic tumors and cysts of the jaw.

TURKISH JOURNAL OF PATHOLOGY (2022)

Review Medicine, Research & Experimental

Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics

Yuan Zhou, Li Zhang, You-Hua Xie, Jian Wu

Summary: This review highlights the importance of sensitive and reliable assays for SARS-CoV-2 detection during the COVID-19 pandemic, and provides guidelines for selecting optimal assays for specific usage. The review discusses the advantages, disadvantages, and specific applications of various assays for detection of viral nucleic acids, genomes, proteins, and host antibody responses.

LABORATORY INVESTIGATION (2022)

Review Pathology

PI3K/Akt/mTOR signaling pathway in cancer stem cells

Mohsen Karami Fath, Menooa Ebrahimi, Ehsan Nourbakhsh, Ahmad Zia Hazara, Ali Mirzaei, Saba Shafieyari, Azadeh Salehi, Mahsa Hoseinzadeh, Zahra Payandeh, Ghasem Barati

Summary: Cancer stem cells (CSCs) play a crucial role in tumor formation and resistance to therapy. Understanding the PI3K/Akt/mTOR signaling pathway in CSCs can provide insights into targeted therapy for drug-resistant tumors. While this pathway is well-known in tumor bulk, its functions in CSCs have not been fully explored.

PATHOLOGY RESEARCH AND PRACTICE (2022)

Review Pathology

COVID-19 and Immune-Mediated RBC Destruction A Systematic Review

Jeremy W. Jacobs, Garrett S. Booth

Summary: SARS-CoV-2 infection and vaccination can lead to autoimmune hemolytic anemia (AIHA), with various subtypes occurring approximately 7 days after infection symptoms and 5 days after vaccination.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2022)

Review Pathology

Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute

Mahmut Akgul, Khaleel Al-Obaidy, Liang Cheng, Muhammad T. Idrees

Summary: A study at Indiana University Department of Pathology identified low-grade oncocytic tumour (LOT) as a potentially distinct entity within primary renal epithelial neoplasms, characterized by distinguishable morphology and immunohistochemical profile. Further research with larger cohorts and comprehensive molecular evaluation is needed to definitively recognize LOT as a separate entity and explore active surveillance options for eligible patients.

JOURNAL OF CLINICAL PATHOLOGY (2022)